Related references
Note: Only part of the references are listed.Microarray-based detection and expression analysis of ABC and SLC transporters in drug-resistant ovarian cancer cell lines
Radoslaw Januchowski et al.
BIOMEDICINE & PHARMACOTHERAPY (2013)
The hOCT1 SNPs M420del and M408V alter imatinib uptake and M420del modifies clinical outcome in imatinib-treated chronic myeloid leukemia
Athina Giannoudis et al.
BLOOD (2013)
ABCG2: recent discovery of potent and highly selective inhibitors
Florine Lecerf-Schmidt et al.
FUTURE MEDICINAL CHEMISTRY (2013)
Q141K polymorphism of ABCG2 protein is associated with poor prognosis in adult acute myeloid leukemia treated with idarubicin-based chemotherapy
M. Tiribelli et al.
HAEMATOLOGICA (2013)
Expression of SLC22A1 Variants May Affect the Response of Hepatocellular Carcinoma and Cholangiocarcinoma to Sorafenib
Elisa Herraez et al.
HEPATOLOGY (2013)
IMP3 Protein Promotes Chemoresistance in Breast Cancer Cells by Regulating Breast Cancer Resistance Protein (ABCG2) Expression
Sanjoy Samanta et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
The ABCs of membrane transporters in health and disease (SLC series): Introduction
Matthias A. Hediger et al.
MOLECULAR ASPECTS OF MEDICINE (2013)
Tumor-Specic Expression of Organic Anion-Transporting Polypeptides: Transporters as Novel Targets for Cancer Therapy
Veronika Buxhofer-Ausch et al.
JOURNAL OF DRUG DELIVERY (2013)
Expression of ABCG2 associated with tumor response in metastatic colorectal cancer patients receiving first-line FOLFOX therapy - preliminary evidence
Pei-Ching Lin et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS (2013)
Influence of Cytochrome P450 2C19 Gene Variations on Pharmacokinetic Parameters of Thalidomide in Japanese Patients
Naoki Matsuzawa et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2012)
Overcoming nucleoside analog chemoresistance of pancreatic cancer: A therapeutic challenge
Sau Wai Hung et al.
CANCER LETTERS (2012)
The major vault protein mediates resistance to epidermal growth factor receptor inhibition in human hepatoma cells
Annemarie Losert et al.
CANCER LETTERS (2012)
Genetic Variants in Oxidative Stress-Related Genes Predict Chemoresistance in Primary Breast Cancer: A Prospective Observational Study and Validation
Ke-Da Yu et al.
CANCER RESEARCH (2012)
Role of the Human High-Affinity Copper Transporter in Copper Homeostasis Regulation and Cisplatin Sensitivity in Cancer Chemotherapy
Macus Tien Kuo et al.
CANCER RESEARCH (2012)
Genetic Variants in Genes Involved in Mechanisms of Chemoresistance to Anticancer Drugs
J. J.G. Marin et al.
CURRENT CANCER DRUG TARGETS (2012)
A comprehensive study of polymorphisms in ABCB1, ABCC2 and ABCG2 and lung cancer chemotherapy response and prognosis
Daniele Campa et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
No Correlation between the Expression of FXR and Genes Involved in Multidrug Resistance Phenotype of Primary Liver Tumors
P. Martinez-Becerra et al.
MOLECULAR PHARMACEUTICS (2012)
Cisplatin-Induced Chemoresistance in Colon Cancer Cells Involves FXR-Dependent and FXR-independent Up-Regulation of ABC Proteins
Elisa Herraez et al.
MOLECULAR PHARMACEUTICS (2012)
Meta-Analysis on Pharmacogenetics of Platinum-Based Chemotherapy in Non Small Cell Lung Cancer (NSCLC) Patients
Ji-Ye Yin et al.
PLOS ONE (2012)
Polymorphism in multidrug resistance-associated protein gene 3 is associated with outcomes in childhood acute lymphoblastic leukemia
M. Ansari et al.
PHARMACOGENOMICS JOURNAL (2012)
Pharmacokinetic Impact of SLCO1A2 Polymorphisms on Imatinib Disposition in Patients With Chronic Myeloid Leukemia
Y. Yamakawa et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2011)
Correlation between genetic polymorphisms of the hOCT1 and MDR1 genes and the response to imatinib in patients newly diagnosed with chronic-phase chronic myeloid leukemia
Margherita Maffioli et al.
LEUKEMIA RESEARCH (2011)
Multidrug resistance gene (MDR1) polymorphisms correlate with imatinib response in chronic myeloid leukemia
Ling-Na Ni et al.
MEDICAL ONCOLOGY (2011)
DNA methylation is associated with downregulation of the organic cation transporter OCT1 (SLC22A1) in human hepatocellular carcinoma
Elke Schaeffeler et al.
GENOME MEDICINE (2011)
Polymorphisms in the multiple drug resistance protein 1 and in P-glycoprotein 1 are associated with time to event outcomes in patients with advanced multiple myeloma treated with bortezomib and pegylated liposomal doxorubicin
Gabriele Buda et al.
ANNALS OF HEMATOLOGY (2010)
ABCG2 421C>A polymorphism and high exposure of sunitinib in a patient with renal cell carcinoma
T. Mizuno et al.
ANNALS OF ONCOLOGY (2010)
The association of reduced folate carrier 80G>A polymorphism to outcome in childhood acute lymphoblastic leukemia interacts with chromosome 21 copy number
Jannie Gregers et al.
BLOOD (2010)
MRP2 and GSTP1 polymorphisms and chemotherapy response in advanced non-small cell lung cancer
Ning Sun et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2010)
Molecular Bases of Liver Cancer Refractoriness to Pharmacological Treatment
J. J. G. Marin et al.
CURRENT MEDICINAL CHEMISTRY (2010)
Strategies for Overcoming Chemotherapy Resistance in Enterohepatic Tumours
J. J. G. Marin et al.
CURRENT MOLECULAR MEDICINE (2010)
Molecular genetics and epigenetics of the cytochrome P450 gene family and its relevance for cancer risk and treatment
Cristina Rodriguez-Antona et al.
HUMAN GENETICS (2010)
Mammalian copper-transporting P-type ATPases, ATP7A and ATP7B: Emerging roles
Sharon La Fontaine et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2010)
ABCB1/MDR1 gene polymorphisms as a prognostic factor in colorectal cancer
Ewa Balcerczak et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2010)
Promoter polymorphism of MRP1 associated with reduced survival in hepatocellular carcinoma
Jing Zhao et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2010)
A synonymous polymorphism in a common MDR1 (ABCB1) haplotype shapes protein function
King Leung Fung et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2009)
Polymorphisms in multidrug resistance-associated protein gene 4 is associated with outcome in childhood acute lymphoblastic leukemia
Marc Ansari et al.
BLOOD (2009)
Clinical Relevance of a Pharmacogenetic Approach Using Multiple Candidate Genes to Predict Response and Resistance to Imatinib Therapy in Chronic Myeloid Leukemia
Dong Hwan (Dennis) Kim et al.
CLINICAL CANCER RESEARCH (2009)
Association of the c.3972C > T Variant of the Multidrug Resistance-Associated Protein 2 Gene (MRP2/ABCC2) with Susceptibility to Bile Duct Cancer
A. Hoeblinger et al.
DIGESTION (2009)
Hepatobiliary transporters in the pharmacology and toxicology of anticancer drugs
Jose J. G. Marin et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2009)
Polymorphisms in ABCG2, ABCC3 and CNT1 genes and their possible impact on chemotherapy outcome of lung cancer patients
Phillip J. Mueller et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
ABCB1 gene polymorphisms and haplotype analysis in colorectal cancer
Mariusz Panczyk et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2009)
Expression of the multidrug resistance proteins MRP2 and MRP3 in human cholangiocellular carcinomas
S. Rau et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2008)
ABCB1 G1199A polymorphism and ovarian cancer response to paclitaxel
Henrik Green et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2008)
Polymorphisms in transporter and phase II metabolism genes as potential modifiers of the predisposition to and treatment outcome of de novo acute myeloid leukemia in Israeli ethnic groups
Phillip Mueller et al.
LEUKEMIA RESEARCH (2008)
NAD(P)H:quinone oxidoreductase 1 NQO1☆2 genotype (P187S) is a strong prognostic and predictive factor in breast cancer
Rainer Fagerholm et al.
NATURE GENETICS (2008)
Expression of MRP1 gene in acute leukemia
Frouzandeh Mahjoubi et al.
SAO PAULO MEDICAL JOURNAL (2008)
Expression of the uptake drug transporter hOCT1 is an important clinical determinant of the response to imatinib in chronic myeloid leukemia
L. Wang et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
Polymorphisms of CYP2C19 gene are associated with the efficacy of thalidomide-based regimens in multiple myeloma
Yonghua Li et al.
HAEMATOLOGICA (2007)
Polyspecific organic cation transporters: Structure, function, physiological roles, and biopharmaceutical implications
Hermann Koepsell et al.
PHARMACEUTICAL RESEARCH (2007)
Associations of ABCB1, ABCC2, and ABCG2 polymorphisms with irinotecan-pharmacokinetics and clinical outcome in patients with advanced non-small cell lung cancer
Ji-Youn Han et al.
CANCER (2007)
High-dose methotrexate in pediatric acute lymphoblastic leukemia:: Impact of ABCC2 polymorphisms on plasma concentrations
Thomas Rau et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2006)
Expression of transporters potentially involved in the targeting of cytostatic bile acid derivatives to colon cancer and polyps
Maria R. Ballestero et al.
BIOCHEMICAL PHARMACOLOGY (2006)
Membrane transporters and channels in chemoresistance and -sensitivity of tumor cells
Ying Huang et al.
CANCER LETTERS (2006)
Cellular functions of vaults and their involvement in multidrug resistance
E. Steiner et al.
CURRENT DRUG TARGETS (2006)
Interaction of methotrexate with organic-anion transporting polypeptide 1A2 and its genetic variants
Ilaria Badagnani et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
ABCG2 expression is an independent unfavorable prognostic factor in Esophageal squamous cell carcinoma
Shigeru Tsunoda et al.
ONCOLOGY (2006)
MRP3, BCRR and P-glycoprotein activities are prognostic factors in adult acute myeloid leukemia
Z Benderra et al.
CLINICAL CANCER RESEARCH (2005)
Hepatobiliary transporter expression in human hepatocellular carcinoma
G Zollner et al.
LIVER INTERNATIONAL (2005)
Inhibition of the epidermal growth factor receptor increases expression of genes that stimulate inflammation, apoptosis, and cell attachment
CD Woodworth et al.
MOLECULAR CANCER THERAPEUTICS (2005)
Association of cyclophosphamide pharmacokinetics to polymorphic cytochrome P4502C19
R Timm et al.
PHARMACOGENOMICS JOURNAL (2005)
CYP2D6 genotype, antidepressant use, and tamoxifen metabolism during adjuvant breast cancer treatment
Y Jin et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
Prognostic value of the Cu-transporting ATPase in ovarian carcinoma patients receiving cisplatin-based chemotherapy
K Nakayama et al.
CLINICAL CANCER RESEARCH (2004)
Nucleoside transporters in chronic lymphocytic leukaemia
M Pastor-Anglada et al.
LEUKEMIA (2004)
Genetic polymorphisms in the multidrug resistance-associated protein 3 (ABCC3, MRP3) gene and relationship to its mRNA and protein expression in human liver
T Lang et al.
PHARMACOGENETICS (2004)
The SLC22 drug transporter family
H Koepsell et al.
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2004)
Organic anion transporting polypeptides of the OATP/SLC21 family:: phylogenetic classification as OATP/SLCO superfamily, new nomenclature and molecular/functional properties
B Hagenbuch et al.
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2004)
Cisplatin rapidly down-regulates its own influx transporter hCTR1 in cultured human ovarian carcinoma cells
AK Holzer et al.
CLINICAL CANCER RESEARCH (2004)
Active transport of imatinib into and out of cells: implications for drug resistance
J Thomas et al.
BLOOD (2004)
Effects of prednisone and genetic polymorphisms on etoposide disposition in children with acute lymphoblastic leukemia
S Kishi et al.
BLOOD (2004)
Cisplatin: mode of cytotoxic action and molecular basis of resistance
ZH Siddik
ONCOGENE (2003)
Natural variation in human membrane transporter genes reveals evolutionary and functional constraints
MK Leabman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
A novel mutant allele of the CYP2A6 gene (CYP2A6*11) found in a cancer patient who showed poor metabolic phenotype towards tegafur
S Daigo et al.
PHARMACOGENETICS (2002)
Polymorphisms of UDP-glucuronosyltransferase and pharmacokinetics of irinotecan
Y Ando et al.
THERAPEUTIC DRUG MONITORING (2002)
Expression of P-glycoprotein in hepatocellular carcinoma - A determinant of chemotherapy response
IOL Ng et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2000)
Share Paper
